We can't have anything getting in the way of #DigitalGreenPass (es) #CommonPass (es), etc..
There's just so much at play here.
#GreenZones #Ivermectin #Covid
#Vaccine #wtfpic.twitter.com/PQJaCJ705h
NEW STUDY: “No safety concern is anticipated that would prevent health authorities from assessing the use of #Ivermectin against Covid-19 as a new indication...Also, no severe adverse event has been reported in studies of ivermectin against COVID-19.”
https://www.medincell.com/wp-content/uploads/2021/03/PR_MDCL_safety_ivermectine-50321.pdf …
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
The only “safety concern” is that of big pharma revenue. I hate being cynical but nothing else explains the response to a safe, effective and cheap competitor to the multi-billion dollar vaccine industry. Please tell me I’m wrong and restore my faith in our health authorities.
-
You are correct.
End of conversation
New conversation -
-
-
Did I just read that the FDA is recommending against Ivermectin?!? How?!?
-
A faulty study just came out. So many flaws. They are running with it ...
End of conversation
New conversation -
-
-
@KPromeni@24minuta@tvnova_s@medjunama_novas@RTS_Vesti@N1infoBG@tanjug@Udruzeni@V_MadnessMaster@novarsonline@BetaNewsAgency@O_Parlament Да ли неко сме да пренесе вест?Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
I noticed CNN done a hit piece on Ivermectin.
-
If
#ivermectin works well against C-19 it could be an obstacle to the emergency authorization use of vaccines that would normally take years to be approved because it takes time to make sure they're safe & effective the FDA isn't working for the publichttps://trialsitenews.com/fda-now-cautions-against-ivermectin-the-vested-interests-are-circling-the-wagons/ … - Show replies
New conversation -
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.